...
首页> 外文期刊>Dalton transactions: An international journal of inorganic chemistry >Quinoxaline-2-carboxamide as a carrier ligand in two new platinum(ii) compounds: Synthesis, crystal structure, cytotoxic activity and DNA interaction
【24h】

Quinoxaline-2-carboxamide as a carrier ligand in two new platinum(ii) compounds: Synthesis, crystal structure, cytotoxic activity and DNA interaction

机译:喹喔啉-2-羧酰胺作为两种新型铂(ii)化合物的载体配体:合成,晶体结构,细胞毒性活性和DNA相互作用

获取原文
获取原文并翻译 | 示例
           

摘要

The search for platinum compounds structurally different from cisplatin has led to two new platinum(ii) compounds containing quinoxaline-2-carboxamide as a carrier ligand, i.e. cis-[Pt(qnxca)(MeCN)Cl_2] (1) and the [Pt(qnxca_(-H))(dmso)Cl] (2). Both compounds have been synthesized and characterized using different spectroscopic methods. In addition, single-crystal structures have been determined by X-Ray diffraction for both compounds. In each case a square planar Pt(ii) is present; in (1) the qnxca is monodentate and neutral, whereas in (2) the ligand has lost a hydrogen, to form the anionic chelating ligand abbreviated as qnxca_(-H). The biological activity of both compounds has been investigated in a panel of seven human tumour cells, displaying poor cytotoxic activity, compared to cisplatin. The interaction of the new compounds with 1 or 2 equiv. of 9-ethylguanine has been studied using ~1H NMR, ~(195)Pt NMR and ESI-MS spectroscopy, finding poor reactivity of 1 towards the model base, forming only the monosubstituted adduct. Surprisingly, compound 2, which is more sterically crowded, interacts more efficiently with the 9-EtG, forming a bifunctional adduct with two 9-EtG with substitution of the dmso and the chloride ligand. Unwinding studies of pUC19 plasmid DNA by compound 1 show similar unwinding properties to cisplatin.
机译:寻找结构与顺铂不同的铂化合物已导致了两种新的含喹喔啉-2-羧酰胺作为载体配体的铂(ii)化合物,即顺式[Pt(qnxca)(MeCN)Cl_2](1)和[Pt (qnxca _(-H))(dmso)Cl](2)。两种化合物均已使用不同的光谱方法合成和表征。另外,已经通过X射线衍射确定了两种化合物的单晶结构。在每种情况下,都存在一个方形的平面Pt(ii);在(1)中,qnxca是单齿的并且是中性的,而在(2)中,配体失去了氢,形成了阴离子螯合配体,缩写为qnxca _(-H)。与顺铂相比,已经在一组七个人类肿瘤细胞中研究了这两种化合物的生物活性,显示出较弱的细胞毒性活性。新化合物与1或2当量的相互作用。使用〜1H NMR,〜(195)Pt NMR和ESI-MS光谱对9-乙基鸟嘌呤进行了研究,发现1对模型碱基的反应性较差,仅形成单取代的加合物。令人惊讶地,空间上更拥挤的化合物2与9-EtG更有效地相互作用,与两个9-EtG形成双官能加合物,其被dmso和氯化物配体取代。化合物1对pUC19质粒DNA的展开研究显示与顺铂相似的展开性质。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号